Clinical Trial Update: Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports a Phase 2/Phase 3 study evaluating diclofenac potassium for efficacy in inferior alveolar nerve block for symptomatic irreversib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• DICLOFENAC POTASSIUM (diclofenac potassium)

Snippet

Sponsor: Cairo University | Conditions: Irreversible Pulpitis | Phase 2, Phase 3 | Status: UNKNOWN